share_log

BioNTech | 6-K: Pfizer and BioNtech Provide Update on mRNA-Based Combination Vaccine Program Against Influenza and Covid-19 in Individuals 18-64 Years of Age

BioNTech | 6-K: Pfizer and BioNtech Provide Update on mRNA-Based Combination Vaccine Program Against Influenza and Covid-19 in Individuals 18-64 Years of Age

BioNTech | 6-K:輝瑞和 BioNTech 提供基於 mRNA 的針對 18-64 歲人群的流感和 COVID-19 聯合疫苗計劃的最新情況
美股SEC公告 ·  08/16 06:58
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息